"Emodin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purgative anthraquinone found in several plants, especially Rhamnus frangula. It was formerly used as a laxative, but is now used mainly as tool in toxicity studies.
| Descriptor ID |
D004642
|
| MeSH Number(s) |
D02.455.426.559.847.117.159.205.400 D02.806.100.205.400 D04.615.117.159.205.400
|
| Concept/Terms |
Emodin- Emodin
- Rheum Emodin
- Emodin, Rheum
- Frangulic Acid
- Archin
- Frangula Emodin
- Emodin, Frangula
|
Below are MeSH descriptors whose meaning is more general than "Emodin".
Below are MeSH descriptors whose meaning is more specific than "Emodin".
This graph shows the total number of publications written about "Emodin" by people in this website by year, and whether "Emodin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Emodin" by people in Profiles.
-
Repair and reconstruction of a resected tumor defect using a composite of tissue flap-nanotherapeutic-silk fibroin and chitosan scaffold. Ann Biomed Eng. 2011 Sep; 39(9):2374-87.
-
Sensitive and robust UPLC-MS/MS method to determine the gender-dependent pharmacokinetics in rats of emodin and its glucuronide. J Pharm Biomed Anal. 2011 Apr 05; 54(5):1157-62.
-
Species and gender differences affect the metabolism of emodin via glucuronidation. AAPS J. 2010 Sep; 12(3):424-36.
-
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells. Int J Pharm. 2007 Aug 16; 341(1-2):221-9.
-
Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin Cancer Res. 1999 Feb; 5(2):343-53.